title: Heterozygous PU.1 mutations are associated with acute myeloid leukemia.
authors.forename: Beatrice U
authors.initials: BU
authors.lastname: Mueller
authors.forename: Thomas
authors.initials: T
authors.lastname: Pabst
authors.forename: Motomi
authors.initials: M
authors.lastname: Osato
authors.forename: Norio
authors.initials: N
authors.lastname: Asou
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Johansen
authors.forename: Mark D
authors.initials: MD
authors.lastname: Minden
authors.forename: Gerhard
authors.initials: G
authors.lastname: Behre
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Hiddemann
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Ito
authors.forename: Daniel G
authors.initials: DG
authors.lastname: Tenen
mesh_terms: D000208:Acute Disease; D004252:DNA Mutational Analysis; D004273:DNA, Neoplasm / Q000235:genetics; D005006:Ethnicity / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D007951:Leukemia, Myeloid / Q000208:ethnology / Q000235:genetics*; D009154:Mutation; D009363:Neoplasm Proteins / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D017422:Sequence Analysis, DNA; D015534:Trans-Activators / Q000235:genetics*; D000099232:Proto-Oncogene Protein Spi-1
chemical_list: D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D000099232:Proto-Oncogene Protein Spi-1